Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study
Jong S. Kim, Yeon-Jung Kim, Kyung Bok Lee, Jae Kwan Cha, Jong-Moo Park, Yangha Hwang, Eung-Gyu Kim, Joung-Ho Rha, Jaseong Koo, Jei Kim, Yong-Jae Kim, Woo-Keun Seo, Dong-Eog Kim, Thompson G. Robinson, Richard I. Lindley, Xia Wang, John Chalmers, Craig S. Anderson
J Stroke. 2018;20(1):131-139.   Published online 2018 Jan 31     DOI: https://doi.org/10.5853/jos.2017.01578
Citations to this article as recorded by Crossref logo
Effect of Intravenous Thrombolysis Prior to Mechanical Thrombectomy According to the Location of M1 Occlusion
Jae-Chan Ryu, Boseong Kwon, Yunsun Song, Deok Hee Lee, Jun Young Chang, Dong-Wha Kang, Sun U. Kwon, Jong S. Kim, Bum Joon Kim
Journal of Stroke.2024; 26(1): 75.     CrossRef
A comparison of low- versus standard-dose bridging alteplase in acute ischemic stroke mechanical thrombectomy using indirect methods
Wei Zheng, Hanhan Lei, Gareth Ambler, David J. Werring, Huiying Lin, Xiaojuan Lin, Yi Tang, Jing Wu, Zhaomin Lin, Nan Liu, Houwei Du
Therapeutic Advances in Neurological Disorders.2023; 16: 175628642211448.     CrossRef
Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
Mingfeng Zhai, Shugang Cao, Jinwei Yang, Xiaoyan Cao, Zhong Dong, Wanyin Liu, Yongzhan Fu, Qiyue Guan, Yu Wang, Hongbo Liu
Neurology and Therapy.2023; 12(4): 1105.     CrossRef
Low-dose alteplase for the management of acute ischemic stroke in South Asians: A systematic review on cost, efficacy and safety
Gaurav Nepal, Sanjeev Kharel, Jayant Kumar Yadav, Sushil Kumar Yadav, Riwaj Bhagat, Yow Ka Shing, Megan Coghlan, Shiva Lal Bhattarai, Kaushal Sigdel, Bishow Chandra Mahat
Journal of Clinical Neuroscience.2022; 103: 92.     CrossRef
Analyses on safety and efficacy of non-standard dose of r-tPA in intravenous thrombolysis-treated AIS patients
Jiawen Yuan, Ruxing Wu, Jingyan Xiang, Jiangshan Deng, Xiaojie Zhang, Kaili Lu, Fengya Cao, Fei Zhao, Yuwu Zhao, Feng Wang
Frontiers in Neurology.2022;[Epub]     CrossRef
Effect of intravenous thrombolysis with alteplase on clinical efficacy, inflammatory factors, and neurological function in patients with acute cerebral infarction
Jinhua Wang, Xia Fang, Dongliang Wang, Yuan Xiao
Brazilian Journal of Medical and Biological Research.2021;[Epub]     CrossRef
The benefit of intravenous thrombolysis prior to mechanical thrombectomy within the therapeutic window for acute ischemic stroke
Joseph Waller, Parveer Kaur, Amy Tucker, Rami Amer, Sonu Bae, Ann Kogler, Muhammad Umair
Clinical Imaging.2021; 79: 3.     CrossRef
Low-Dose vs. Standard-Dose Intravenous Alteplase in Bridging Therapy Among Patients With Acute Ischemic Stroke: Experience From a Stroke Center in Vietnam
Duy Ton Mai, Viet Phuong Dao, Van Chi Nguyen, Dang Luu Vu, Tien Dung Nguyen, Xuan Trung Vuong, Quoc Viet Bui, Ha Quan Phan, Quang Tho Pham, Hoang Kien Le, Anh Tuan Tran, Quang Anh Nguyen, Phuc Duc Dang, Hoang Nguyen, Hoang Thi Phan
Frontiers in Neurology.2021;[Epub]     CrossRef
Low-cost alternatives for the management of acute ischemic stroke in low and middle-income countries
Gaurav Nepal, Jayant Kumar Yadav, Siddhartha Bhandari, Jeevan Gautam, Bikram Prasad Gajurel
Annals of Medicine and Surgery.2021; 72: 102969.     CrossRef
Intravenous Thrombolysis Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: Silver Bullet or Useless Bystander?
Federico Di Maria, Mikael Mazighi, MaƩva Kyheng, Julien Labreuche, Georges Rodesch, Arturo Consoli, Oguzhan Coskun, Benjamin Gory, Bertrand Lapergue
Journal of Stroke.2018; 20(3): 385.     CrossRef